Skip to content

Effect test of continuous intake of test food for 8 weeks on endurance and fatigue in healthy adult women

Effect test of continuous intake of test food for 8 weeks on endurance and fatigue in healthy adult women - Effect test of continuous intake of test food for 8 weeks on endurance and fatigue in healthy adult women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039587
Enrollment
30
Registered
2020-03-05
Start date
2020-02-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Healthy Japanese female aged 40 years or older and younger than 70 years at the time of the informed consent. 2.Subject who feels tired on a daily basis. 3.Subject who usually takes three meals a day. 4.Subject who has understood the purpose of the study, and agreed to participate it by signing the written informed consent.

Exclusion criteria

Exclusion criteria: 1.Heavy drinker 2.Subject who has strong exercise habits. 3.Subject who has experienced chest pain or abnormal pulse at rest. 4.Subject who frequently has palpitations, shortness of breath, lightheadedness, dizziness or loss of consciousness. 5.A family member who has died suddenly for unknown reasons. 6.Subject who has been diagnosed as having problems with the legs. 7.Subject who is receiving the rheumatism treatment. 8.Subject with a history of knee surgery or disease, or who regularly use of cane. 9.Subject with severe hay fever symptoms affecting fatigue. 10.Subject whose protein intake is restricted by a doctor (including mild restrictions). 11.Subject who is taking medication or under medical treatment because of some serious disease. 12.Subject who is under exercise therapy or dietetic therapy. 13.Subject who has an allergy for test food(27 items: milk, soy). 14.Subject who has or had a history of either medicine or alcohol dependence syndrome. 15.Subject who has or had a history of mental illness (depression) or sleep disturbance.

Design outcomes

Primary

MeasureTime frame
1)Primary efficacy assessment VAS questionnaire

Secondary

MeasureTime frame
2)Secondary evaluation of effectiveness POMS2 shortened version,body composition,shuttle stamina walk test 3)Safety evaluation Vital signs,biochemical tests, hematological tests,adverse events

Countries

Japan

Contacts

Public ContactDaisuke Ochitani

HUMA R&D CORP Clinical Development Division

ochitani@huma-rd.co.jp03-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026